Skip to main content
. 2019 Jun 5;17(6):e05709. doi: 10.2903/j.efsa.2019.5709

Figure 2.

Figure 2

Flow chart presenting a generic process of use of WGS by the MSs on a voluntary basis for the specific monitoring of ESBL‐/AmpC‐/carbapenemase‐producing E. coli within the framework of the harmonised monitoring of AMR, with possibility to report either encoding genes (by now) or sequences (in future) to EFSA, and the necessary quality steps